Related MeSH Hierarchy (5)
Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Cardiomyopathies » Myocardial Reperfusion Injury
Diseases [C] » Cardiovascular Diseases [C14] » Heart Diseases » Myocardial Ischemia » Myocardial Reperfusion Injury
Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Myocardial Ischemia » Myocardial Reperfusion Injury
Diseases [C] » Cardiovascular Diseases [C14] » Vascular Diseases » Reperfusion Injury » Myocardial Reperfusion Injury
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Postoperative Complications » Reperfusion Injury » Myocardial Reperfusion Injury
Description
Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. MeSH
Hierarchy View
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (4)
Phase 1 Indicated Drugs (1)
Other Experimental Indicated Drugs (4)
Organization Involved with Phase 4 Indications (12)
Organization Involved with Phase 3 Indications (5)
Organization Involved with Phase 2 Indications (14)
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.